IP Verse

Sangamo Biosciences competitive analysis

Loading summary...

Latest patents of Sangamo Biosciences opposed by its competitors

Explore Sangamo Biosciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3196301
Oct 17, 2018Methods And Compositions For The Treatment Of Monogenic Diseases3

Latest publications and patents of Sangamo Biosciences New

Explore the latest publications and patents granted to Sangamo Biosciences, showcasing their recent innovations and technological advancements.

Last updated on: Oct 22, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Sangamo Biosciences

EP3196301
Oct 17, 2018Methods And Compositions For The Treatment Of Monogenic DiseasesRevoked
EP1651660
Jan 24, 2018Methods And Compositions For Targeted Cleavage And RecombinationNo Opposition Filed Within Time Limit
EP2419511
Jan 17, 2018Targeted Integration Into Stem CellsNo Opposition Filed Within Time Limit
EP2344660
Jan 17, 2018Methods And Compositions For Inactivating Glutamine Synthetase Gene ExpressionNo Opposition Filed Within Time Limit

Latest PTAB cases involving Sangamo Biosciences

Discover the latest PTAB cases involving Sangamo Biosciences, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sangamo Biosciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANGAMO BIOSCIENCES - 3 - -
LEEMING13 - - -
MATHYS & SQUIRE54 - - -
PATENT BOUTIQUE43 - - -